Key result
Ingramon-depot linked to less severe myocardial necrosis in obese db/db mice.
Why the study?
To evaluate structural and functional features of the myocardium in db/db mice and assess the impact of prolonged depot Ingramon on the left ventricular myocardium.
Does prolonged administration of Ingramon-depot improve structural and functional features of the myocardium in obese db/db mice?
Does prolonged administration of Ingramon-depot improve structural and functional features of the myocardium in obese db/db mice?
In a mouse model of metabolic syndrome and early HFpEF, prolonged administration of Ingramon-depot reduced the severity of myocardial necrotic changes.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Ingramon-depot effects in diabetic cardiomyopathy models; human trials needed before any clinical consideration.
Objective. To assess structural and functional features of the myocardium in db/db mice through heart ultrasound, histology, and immunofluorescence; to evaluate the impact of prolonged depot Ingramon on the left ventricular (LV) myocardium. Material and methods. The study was conducted on C5bl/KsJ-db/db and C57bl/6 mice. From 4 months of age, db/db mice received 30 mg/kg (1200 μg/mouse) of Ingramon-depot subcutaneously every two weeks. Cardiac ultrasound was performed using a VEVO1100 system (Visualsonics, Toronto, Canada). Histological analysis of LV myocardium was conducted using cryostat and paraffin slices stained with haematoxylin / eosin and Masson’s trichrome. The sliceslices were also stained with F4/80 antibodies to detect macrophages. Results. Impaired LV relaxation was observed in db/db mice from an early age. Morphological evaluation of the LV myocardium in 8- and 12-month-old db/db mice demonstrated features characteristic of diabetic cardiomyopathy, including hypertrophy of cardiomyocyte clusters, distinct cytoplasmic alterations, and evidence of cardiomyocyte destruction. Conclusion. Age-related structural and functional changes in myocardium of db/db and C57bl/6 mice indicated LV diastolic dysfunction. Early stages of HFpEF under metabolic syndrome in db/db mice are suggested by histological data. The administration of Ingramon-depot was associated with less severe necrotic changes in myocardium.
No takes yet. Share an insight, caveat, or question.
Radyukhina et al. (2026) studied this question. Ingramon-depot administration was associated with less severe necrotic changes in the myocardium of obese db/db mice.
Synapse has enriched 10 related papers. Consider them for comparative context: